Product logins

Find logins to all Clarivate products below.


Clot Management Devices | Japan | 2016 | Market Analysis

The Japanese market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of AV access thrombosis, PADVTECAD, and AIS.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for clot management devices in Japan across a 10-year period.

Related Medtech Insights Reports

Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…
Report
Small-Joint Reconstructive Implants – Market Insights – Japan
The Japanese smalljoint reconstructive implant market, covering shoulder and elbow arthroplasty, exhibits longterm growth potential. Procedure volumes are rising steadily, driven by Japan’s…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…